ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non- ST-Elevation Myocardial Infarction) developed in collaboration with the AmericanCollege of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1-157. 461. Canto JG, Shlipak MG, Rogers WJ, Malmgren JA, Frederick PD, Lambrew CT, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283(24):3223-9. 462. Culic V, Eterovic D, Miric D, Silic N. Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors. Am Heart J. 2002;144(6):1012-7. 463. Brieger D, Eagle KA, Goodman SG, Steg PG, Budaj A, White K, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004;126(2):461-9. 464. Canto JG, Fincher C, Kiefe CI, Allison JJ, Li Q, Funkhouser E, et al. Atypical presentationsamongMedicarebeneficiarieswithunstableanginapectoris. Am J Cardiol. 2002;90(3):248-53. 465. Cambou JP, Simon T, Mulak G, Bataille V, Danchin N. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST- MI): study design and baseline characteristics. Arch Mal Coeur Vaiss. 2007;100(6-7):524-34. 466. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581-98. 467. AmsterdamEA,Wenger NK, Brindis RG, Casey Jr DE, Ganiats TG, Holmes Jr DR, et al. 2014 AHA/ACC guideline for themanagement of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):e344-426. 468. Januzzi JL Jr, Bamberg F, Lee H, Truong QA, Nichols JH, Karakas M, et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation. 2010;121(10):1227-34. 469. Tomonaga Y, Gutzwiller F, Luscher TF, Riesen WF, Hug M, Diemand A, et al. Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. BMC FamPract. 2011Mar 24;12:12. 470. Armstrong PW, Fu Y, Chang WC, Topol EJ, Granger CB, Betriu A, et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation. 1998;98(18):1860-8. 471. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol. 2001;37(6):1571-80. 472. Nicolau JC, Timerman A, Marin-Neto JA, Piegas LS, Barbosa CJDG, Franci A, et al. Diretrizes da Sociedade Brasileira de Cardiologia sobre angina instável e infarto agudo domiocárdio sem supradesnível do segmento ST. Arq Bras Cardiol. 2014;102(3Supl.1):1-61. 473. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55(23):2556-66. 474. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835-42. 475. Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, CohenM, et al. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. AmHeart J. 2002;143(6):966-70. 476. MorrowDA,AntmanEM,SnapinnSM,McCabeCH,TherouxP,Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23(3):223-9. 477. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-53. 478. Maroko PR, Radvany P, Braunwald E, Hale SL. Reduction of infarct size by oxygen inhalation following acute coronary occlusion. Circulation. 1975;52(3):360-8. 479. Kelly RF, Hursey TL, Parrillo JE, Schaer GL. Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. Am Heart J. 1995;130(5):957-65. 480. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, et al. Air versus oxygen in ST-Segment-ElevationMyocardial Infarction. Circulation. 2015;131(24):2143-50. 481. Borzak S, Cannon CP, Kraft PL, Douthat L, Becker RC, Palmeri ST, et al. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. Am J Cardiol. 1998;81(6):678-81. 482. Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, et al. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes. 2009;2(3):155-63. 483. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H,et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presentingwith ST-segment elevation: The Task Force for themanagement of acutemyocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). . Eur Heart J. 2018;39(2):119-77. 484. Hofmann R, James SK, Jernberg T, Lindahl B, Erlinge D, Witt N, et al. Oxygen therapy in suspected acute myocardial infarction. N Engl J Med. 2017;377(13):1240-9. 485. ISIS-2 (Second International Study of Infarct Survival) CollaborativeGroup. Randomisedtrialof intravenousstreptokinase,oralaspirin,both,orneither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988 Aug 13;2(8607):349-60. 486. Freimark D, Matetzky S, Leor J, Boyko V, Barbash IM, Behar S, et al. Timing of aspirin administration as a determinant of survival of patients with acutemyocardial infarction treated with thrombolysis. Am J Cardiol. 2002;89(4):381-5. 487. CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010;363(10):930-42. 488. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502. 489. WiviottSD,BraunwaldE,McCabeCH,MontalescotG,RuzylloW,Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001-15. 490. Ruff CT, Giugliano RP, Antman EM, Murphy SA, Lotan C, Heuer H, et al. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world. Int J Cardiol. 2012;155(3):424-9. 638